3Kearon C, kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease.. American college of chest physicians Evidence - based clinical practice Guidelines (8th Edition)[J]. Chest , 2008,133 (6 Suppl):454-545.
4Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community [ J ]. Thromb Haemost, 2001, 86( 1 ) :452-463.
5Spyropoulos A, Merli G. Management of Venous Thromboembolism in the Elderly[J]. Drugs Aging, 2006, 23(8) :651-671.
6Hach W. Die Entwicklung der groβen Venenchirurgie in Europa [J]. Der Chirurg, 2000, 71(3) :337-341.
7Forster A J, Wells PS, Philip S, et al. The rationale and evidence for the treatment of lower - extremity deep venous thrombosis with thrombolytic agents[J]. Curr Opin Hematol, 2002, 9(5) :437-442.
8Hirsh J, Lensing AW. Thrombolytic therapy for deep vein thrombosis [ J].Int Angiol, 1996, 15 ( suppl 5) :22-25.
9Janssen MCH, Wollershein H, Schultze kool LJ, et al. Local and systemic thrombolytic therapy for acute deep venous thrombosis [ J]. Neth J Med, 2005, 63(3):81-90.
10Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis [ J ]. J Vasc lnterv Radiol, 1991, 2(2) :195-200.
